A recent study highlighted the same problem with an Erk FRET reporter and Erk-KTR, where Cdk1-dependent reporter activity increased in late G2 phase in human colorectal cancer cells.22 Thus, modErk-KTR will be a valuable tool, providing an improved biosensor for use in vitro and in vivo. This evidence concerns the gene CDK1 and colorectal cancer.